- Report
- March 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- February 2022
- 258 Pages
Global
From €3529EUR$3,712USD£2,965GBP
- Book
- April 2008
- 538 Pages
Blood Plasma is a vital component of the pharmaceutical industry, used in the production of a variety of drugs and treatments. It is a component of the human body that is collected from healthy donors and used to create a range of products, including immunoglobulins, albumin, clotting factors, and other proteins. Plasma is also used to manufacture a variety of vaccines, including those for influenza, hepatitis, and rabies.
The demand for blood plasma has grown in recent years due to the increasing prevalence of chronic diseases and the need for more effective treatments. As a result, the market for blood plasma has become increasingly competitive, with a number of companies vying for a share of the market.
Some of the major players in the blood plasma market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. These companies are involved in the collection, processing, and distribution of blood plasma products, as well as the development of new treatments and therapies. Show Less Read more